Your browser doesn't support javascript.
loading
A lung adenocarcinoma patient harboring MET c. 3028 + 2 T >A variant sensitive to crizotinib treatment.
Jiang, Rui; Wei, Dongguang; Tan, Yuan; Duan, Qianqian.
Affiliation
  • Jiang R; Department of Pulmonary and Critical Care Medicine, Shanxi Provincial People's Hospital, Shanxi, China. mydream3g@126.com.
  • Wei D; Department of Pulmonary and Critical Care Medicine, Shanxi Provincial People's Hospital, Shanxi, China.
  • Tan Y; The Medical Department, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd; Nanjing Simcere Medical Laboratory Science Co., Ltd; Jiangsu Simcere Diagnostics Co., Ltd; Xuanwu District, Building 5, No. 699-18 Xuanwu Avenue, Nanjing, Jiangs
  • Duan Q; The Medical Department, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd; Nanjing Simcere Medical Laboratory Science Co., Ltd; Jiangsu Simcere Diagnostics Co., Ltd; Xuanwu District, Building 5, No. 699-18 Xuanwu Avenue, Nanjing, Jiangs
Invest New Drugs ; 40(4): 870-873, 2022 08.
Article in En | MEDLINE | ID: mdl-35551560
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma of Lung / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Invest New Drugs Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma of Lung / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Invest New Drugs Year: 2022 Type: Article Affiliation country: China